OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $249,817 Invested

2023

NeuroAge Therapeutics

Christin Glorioso, MD, PhD

A multi-omics brain aging test for tracking cognitive sharpness and risk of dementia

  • Funding Amount: $249,817
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Epigenetics
  • Status: Active